Citi Reiterates Neutral Rating on Arrowhead Pharma (ARWR)
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/20/2026
- Nasdaq climbs as chip and AI-linked stocks bounce back
- U.S. economy is "booming," JPMorgan’s Dimon says
- Musk pledges one share of SpaceX to every U.S. child
- Brent crude edges lower, even after Houthi attacks on Saudi infrastructure
- Prepare to buy the dip as U.S. stock selloff nears its end: Morgan Stanley
| ARROWHEAD RESEARCH (NASDAQ: ARWR) | Delayed: 57.23 +1.33 (2.38%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $55.90 | 52 Week High | $8.22 | |||
| Open | $56.96 | 52 Week Low | $3.07 | |||
| Day High | $57.30 | P/E | N/A | |||
| Day Low | $56.05 | EPS | $-1.30 | |||
| Volume | 1,646,985 | |||||
